Check Out What Whales Are Doing With BMY
Portfolio Pulse from Benzinga Insights
A significant bullish stance has been taken on Bristol-Myers Squibb (NYSE:BMY) by a large investor or institution, as indicated by unusual options trading activity. The sentiment among these big-money traders is split, with 63% bullish and 36% bearish. The targeted price range for BMY over the last three months appears to be $62.5 to $65.0. Truist Securities has downgraded its action to Buy with a price target of $84.
June 30, 2023 | 4:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bristol-Myers Squibb has seen significant bullish options trading activity, indicating a potential positive short-term impact on the stock. Truist Securities has downgraded its action to Buy with a price target of $84.
The unusual options trading activity indicates that large investors or institutions are taking a bullish stance on Bristol-Myers Squibb, which could potentially drive the stock price up in the short term. Additionally, the downgrade by Truist Securities to Buy with a price target of $84 suggests a positive outlook for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100